ÂÜÀòÂÒÂ×

Nicola joined Enara Bio in 2019 to lead the establishment of specialized immunopeptidomics facilities at the company and to guide research into Dark Antigen discovery.

Nicola concurrently holds an academic appointment at the University of Oxford where she heads the Antigen Discovery Group, specialising in sequencing the immunopeptidomes of multiple pathogen infection models, and analysis of the antigenic landscape of cancer and autoimmune diseases. This builds on Nicola’s postdoctoral research in Oxford where she utilized nanoflow ultra-performance liquid chromatography tandem mass spectrometry to identify viral antigens for the development of T-cell vaccines.

Nicola trained in Physics and Biochemistry at the Universities of Bonn, Greifswald and Bochum in Germany, and obtained her PhD evaluating DNA vaccines for Respiratory Syncytial Virus at the Institute for Molecular and Medical Virology in Bochum.